Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Bevacizumab, CPT-11 and Carboplatin in
combination are effective in the treatment of recurrent malignant glioma.